Herborium Financial Statements From 2010 to 2024

HBRMDelisted Stock  USD 0.0001  0.00  0.00%   
Herborium financial statements provide useful quarterly and yearly information to potential Herborium Group investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Herborium financial statements helps investors assess Herborium's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Herborium's valuation are summarized below:
Herborium Group does not presently have any fundamental trends for analysis.
Check Herborium financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Herborium's main balance sheet or income statement drivers, such as , as well as many indicators such as . Herborium financial statements analysis is a perfect complement when working with Herborium Valuation or Volatility modules.
  
This module can also supplement various Herborium Technical models . Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Herborium Group Company Current Valuation Analysis

Herborium's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Herborium Current Valuation

    
  220.29 K  
Most of Herborium's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Herborium Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Herborium Group has a Current Valuation of 220.29 K. This is 100.0% lower than that of the Personal Products sector and significantly higher than that of the Consumer Staples industry. The current valuation for all United States stocks is 100.0% higher than that of the company.

Herborium Group Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Herborium's current stock value. Our valuation model uses many indicators to compare Herborium value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Herborium competition to find correlations between indicators driving Herborium's intrinsic value. More Info.
Herborium Group is one of the top stocks in profit margin category among its peers. It also is one of the top stocks in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Herborium's earnings, one of the primary drivers of an investment's value.

About Herborium Financial Statements

Herborium investors utilize fundamental indicators, such as revenue or net income, to predict how Herborium Pink Sheet might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Herborium Group, Inc., a botanical therapeutics company, develops, licenses, and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The company was founded in 2000 and is headquartered in Fort Lee, New Jersey. Herborium operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 2 people.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Consideration for investing in Herborium Pink Sheet

If you are still planning to invest in Herborium Group check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Herborium's history and understand the potential risks before investing.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Bonds Directory
Find actively traded corporate debentures issued by US companies
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities